NASDAQ
Maze Therapeutics, Inc. (MAZE) has a current ratio of 15.50x as of Tuesday, May 26, 2026. This represents a 174.36% increase compared to its 12-month average of 5.65x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.